It has been reported that knocking out CDKN1A enhances the sensitivity of A549 cells (lung cancer cells) to doxorubicin-induced ferroptosis, suggesting that CDKN1A inhibits ferroptosis [84]. The gene discussed is CDKN1A; the disease is lung carcinoma.